Clinical Trial Update: Aquagenic Pruritus in Myeloproliferative Neoplasms

View source ↗

Summary

A completed clinical trial investigating aquagenic pruritus in patients with myeloproliferative neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelofibrosis
• Myeloproliferative Neoplasms
• Polycythemia Vera

Snippet

Sponsor: University Hospital, Brest | Conditions: Deciphering Aquagenic Pruritus in Myeloproliferaitive Neoplasms | Status: COMPLETED